Sun Pharma near its 7-year high ahead of second quarter results: Buy, sell or hold? Expert suggests strategy

[ad_1]

Sun Pharmaceuticals Industries stocks gained on Tuesday on positive July-September quarter estimates. The scrip quoted Rs 1034 apiece on NSE, up 1 per cent, in afternoon session. The drug maker also hit a fresh 52-week high of Rs 1047 today which also is the counter’s intraday high.

[ad_2]

Source link